Drugs Archives | LowestMed
Taxpayers overpaid how much for EpiPens?

Taxpayers overpaid how much for EpiPens?

According to a U.S. government report, American taxpayers who purchased the anti-allergy device EpiPen, may have been overcharged by as much as $1.27 billion, over the last 10 years. Last year, Mylan Pharmaceuticals, the company that makes EpiPen, agreed to settle...
Reyataz patent expiration & prices

Reyataz patent expiration & prices

The patent for Reyataz, the HIV drug used to treat HIV-1 infections, will expire June 20, 2017. The expiration includes the drug product, drug substance and patent use for a method of treating HIV-1 infection. The pediatric exclusivity for Reyataz will not expire...

Pin It on Pinterest